Soluble heat-shock protein 27 in blood serum is a non-invasive prognostic biomarker for ovarian cancer.

MLA

Könsgen, Dominique, et al. “Soluble Heat-Shock Protein 27 in Blood Serum Is a Non-Invasive Prognostic Biomarker for Ovarian Cancer.” European Journal of Obstetrics, Gynecology, and Reproductive Biology, vol. 255, Dec. 2020, pp. 154–59. EBSCOhost, https://doi.org/10.1016/j.ejogrb.2020.10.044.

APA

Könsgen, D., Klinkmann, G., Kaul, A., Diesing, K., Sehouli, J., Braicu, I., Sümnig, A., Erb, H. H. H., Stope, M. B., & Mustea, A. (2020). Soluble heat-shock protein 27 in blood serum is a non-invasive prognostic biomarker for ovarian cancer. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 255, 154–159. https://doi.org/10.1016/j.ejogrb.2020.10.044

Chicago

Könsgen, Dominique, Gerd Klinkmann, Anne Kaul, Karoline Diesing, Jalid Sehouli, Ioana Braicu, Ariane Sümnig, Holger H H Erb, Matthias B Stope, and Alexander Mustea. 2020. “Soluble Heat-Shock Protein 27 in Blood Serum Is a Non-Invasive Prognostic Biomarker for Ovarian Cancer.” European Journal of Obstetrics, Gynecology, and Reproductive Biology 255 (December): 154–59. doi:10.1016/j.ejogrb.2020.10.044.